[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 800
Citations 0
Clinical Trials Update
August 25, 2015

Diabetes Drug Helps Promote Weight Loss in Obese Patients

JAMA. 2015;314(8):762. doi:10.1001/jama.2015.9949

Results from a recent placebo-controlled trial suggest liraglutide, a glucagon-like peptide-1 analogue approved to treat type 2 diabetes, can help shed body weight and improve glycemic control among people who were very overweight or obese—but not diabetic. The trial, consisting of 3731 participants, also found that participants who had taken liraglutide had a significantly lower incidence of prediabetes after 56 weeks and developed type 2 diabetes at a significantly lower rate compared with participants taking placebo (Pi-Sunyer X et al. N Engl J Med. 2015;373[1]:11-22).

First Page Preview View Large
First page PDF preview
First page PDF preview